Collegium Pharmaceutical, Inc. (COLL) vs Alpha Teknova, Inc. (TKNO)
Collegium Pharmaceutical, Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $737.1M against $498.8M — 1.5× the size. Alpha Teknova, Inc. has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 14.7×. Collegium Pharmaceutical, Inc. grew revenue faster over the last twelve months: 14.3% against 12.3%. Collegium Pharmaceutical, Inc. has the higher net margin (5.93% vs −38.4%) and the higher return on invested capital (7.85% vs −16.9%). Across the 19 metrics below, Collegium Pharmaceutical, Inc. leads on 14 and Alpha Teknova, Inc. on 5.
Valuation
Profitability
| Metric | COLL | TKNO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.02% | 34.60% | 53.94% |
| Operating margin | 19.48% | (36.19%) | 0.00% |
| Net margin | 5.93% | (38.37%) | 0.00% |
| Free cash flow margin | 40.62% | (16.83%) | 0.00% |
| Return on equity | 17.61% | (24.19%) | (0.40%) |
| Return on assets | 2.57% | (16.25%) | (3.32%) |
| Return on invested capital | 7.85% | (16.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack